» Articles » PMID: 19323566

SH3 Domains of Grb2 Adaptor Bind to PXpsiPXR Motifs Within the Sos1 Nucleotide Exchange Factor in a Discriminate Manner

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2009 Mar 28
PMID 19323566
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitously encountered in a wide variety of cellular processes, the Grb2-Sos1 interaction is mediated through the combinatorial binding of nSH3 and cSH3 domains of Grb2 to various sites containing PXpsiPXR motifs within Sos1. Here, using isothermal titration calorimetry, we demonstrate that while the nSH3 domain binds with affinities in the physiological range to all four sites containing PXpsiPXR motifs, designated S1, S2, S3, and S4, the cSH3 domain can only do so at the S1 site. Further scrutiny of these sites yields rationale for the recognition of various PXpsiPXR motifs by the SH3 domains in a discriminate manner. Unlike the PXpsiPXR motifs at S2, S3, and S4 sites, the PXpsiPXR motif at the S1 site is flanked at its C-terminus with two additional arginine residues that are absolutely required for high-affinity binding of the cSH3 domain. In striking contrast, these two additional arginine residues augment the binding of the nSH3 domain to the S1 site, but their role is not critical for the recognition of S2, S3, and S4 sites. Site-directed mutagenesis suggests that the two additional arginine residues flanking the PXpsiPXR motif at the S1 site contribute to free energy of binding via the formation of salt bridges with specific acidic residues in SH3 domains. Molecular modeling is employed to project these novel findings into the 3D structures of SH3 domains in complex with a peptide containing the PXpsiPXR motif and flanking arginine residues at the S1 site. Taken together, this study furthers our understanding of the assembly of a key signaling complex central to cellular machinery.

Citing Articles

The Configuration of GRB2 in Protein Interaction and Signal Transduction.

Wang D, Liu G, Meng Y, Chen H, Ye Z, Jing J Biomolecules. 2024; 14(3).

PMID: 38540680 PMC: 10968029. DOI: 10.3390/biom14030259.


Conserved proline residues prevent dimerization and aggregation in the β-lactamase BlaC.

Chikunova A, Manley M, Heijjer C, Drenth C, Cramer-Blok A, Ahmad M Protein Sci. 2024; 33(4):e4972.

PMID: 38533527 PMC: 10966351. DOI: 10.1002/pro.4972.


Functional Classification and Interaction Selectivity Landscape of the Human SH3 Domain Superfamily.

Kazemein Jasemi N, Mehrabipour M, Magdalena Estirado E, Brunsveld L, Dvorsky R, Ahmadian M Cells. 2024; 13(2).

PMID: 38275820 PMC: 10814857. DOI: 10.3390/cells13020195.


Allosteric regulation of GRB2 modulates RAS activation.

Kazemein Jasemi N, Ahmadian M Small GTPases. 2022; 13(1):282-286.

PMID: 35703160 PMC: 9225496. DOI: 10.1080/21541248.2022.2089001.


SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations.

Liao T, Jang H, Fushman D, Nussinov R J Chem Phys. 2020; 153(4):045106.

PMID: 32752665 PMC: 7390601. DOI: 10.1063/5.0013926.


References
1.
Ferreon J, Hilser V . Ligand-induced changes in dynamics in the RT loop of the C-terminal SH3 domain of Sem-5 indicate cooperative conformational coupling. Protein Sci. 2003; 12(5):982-96. PMC: 2323869. DOI: 10.1110/ps.0238003. View

2.
Chardin P, Camonis J, Gale N, Van Aelst L, Schlessinger J, Wigler M . Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science. 1993; 260(5112):1338-43. DOI: 10.1126/science.8493579. View

3.
Park R, Kyono W, Liu Y, Durden D . CBL-GRB2 interaction in myeloid immunoreceptor tyrosine activation motif signaling. J Immunol. 1998; 160(10):5018-27. View

4.
Zarrinpar A, Bhattacharyya R, Lim W . The structure and function of proline recognition domains. Sci STKE. 2003; 2003(179):RE8. DOI: 10.1126/stke.2003.179.re8. View

5.
Lewitzky M, Kardinal C, Gehring N, Schmidt E, Konkol B, Eulitz M . The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene. 2001; 20(9):1052-62. DOI: 10.1038/sj.onc.1204202. View